Precigen (PGEN) EBT Margin Growth (5y) (2017 - 2026)
Precigen (PGEN) EBT Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,523.00 |
| Dec 31, 2025 | -9,032.00 |
| Sep 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | -335,886.00 |
| Mar 31, 2025 | -396,853.00 |
| Dec 31, 2024 | -31,946.00 |
| Sep 30, 2024 | -239.63 Mn |
| Jun 30, 2024 | -833,688.00 |
| Mar 31, 2024 | -199,736.00 |
| Dec 31, 2023 | -222,512.00 |
| Sep 30, 2023 | -197.99 Mn |
| Jun 30, 2023 | -99,471.00 |
| Dec 31, 2022 | 13,077.00 |
| Sep 30, 2022 | 3,791.00 |
| Jun 30, 2022 | -86,063.00 |
| Mar 31, 2022 | -37,303.00 |
| Dec 31, 2021 | 36,372.00 |
| Sep 30, 2021 | -72,936.00 |
| Jun 30, 2021 | -71,613.00 |
| Mar 31, 2021 | 6,630.00 |